Key result
Among 27 patients with primary antibody deficiency and unexplained elevated liver enzymes, 0% tested positive for HEV-RNA.
Why the study?
Does hepatitis E virus infection explain persistently elevated liver enzymes in patients with primary antibody deficiency?
Observational (n=27)
Does hepatitis E virus infection explain persistently elevated liver enzymes in patients with primary antibody deficiency?
Answers are grounded in this paper and cite their sources.
Despite rising HEV incidence, HEV-RNA was not detected in a small cohort of PAD patients with unexplained liver enzyme elevation, though testing remains recommended.
Data from recent studies suggest rising incidence rate of hepatitis E virus (HEV) infection in the UK. HEV infection may take a severe and persistent course in immunocompromised patients, including transplant recipients on immunosuppressives, patients with HIV, haematological malignancies and in idiopathic CD4 + T lymphocytopenia. The prevalence of HEV in primary antibody deficiency (PAD) disorders is still unknown. The aim of this study was to investigate HEV infection in 27 patients with PAD with unexplained, persistently elevated liver enzymes. Although all the 27 patients tested negative for HEV-RNA, we would still strongly recommend that HEV should be considered in any immunodeficient patient with impaired liver function.
No takes yet. Share an insight, caveat, or question.
Mohamed et al. (2017) conducted an observational in Primary antibody deficiency with unexplained elevated liver enzymes (n=27). Hepatitis E virus (HEV) infection was evaluated on HEV-RNA positivity. Among 27 patients with primary antibody deficiency and unexplained elevated liver enzymes, 0% tested positive for HEV-RNA.
Synapse has enriched 10 related papers. Consider them for comparative context: